CORRESP Filing
COMPASS Pathways plc
Date: May 5, 2025 · CIK: 0001816590 · Accession: 0001816590-25-000057
AI Filing Summary & Sentiment
File numbers found in text: 333-285297
Show Raw Text
CORRESP 1 filename1.htm Document May 5, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Compass Pathways plc Acceleration Request for Registration Statement on Form S-3 (File No. 333-285297) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Compass Pathways plc (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement be accelerated to May 7, 2025, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Benjamin K. Marsh of Goodwin Procter LLP at (212) 813-8816. Sincerely, Compass Pathways plc /s/ Meredith Prithviraj Name: Meredith Prithviraj Title: VP, Associate General Counsel Cc: Kabir Nath, Chief Executive Officer, Compass Pathways plc Benjamin K. Marsh, Goodwin Procter LLP